Login | Users Online: 613  
Home Print this page Email this page Small font sizeDefault font sizeIncrease font size   
Home | About us | Editorial board | Search | Ahead of print | Current Issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contact us
 
This article has been cited by
1Statins and risk of decompensation in hepatitis B virus-related and hepatitis C virus-related cirrhosis: Methodological issues
Chun-Yu Lin
Hepatology.2018;67(3)1174
[DOI]
2Statin use is not associated with liver related mortality
Zahra Younoszai,Li Zheng,Maria Stepanova,Madeline Erario,Rebecca Cable,Zobair M. Younossi
Annals of Hepatology.2014;13(1)84
[DOI]
3Novel treatment options for portal hypertension
Philipp Schwabl,Wim Laleman
Gastroenterology Report.2017;5(2)90
[DOI]
4Change in ALT levels after administration of HMG-CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practice
Hyunah Kim,Hyeseon Lee,Tong Min Kim,So Jung Yang,Seo Yeon Baik,Seung-Hwan Lee,Jae-Hyoung Cho,Hyunyong Lee,Hyeon Woo Yim,In Young Choi,Kun-Ho Yoon,Hun-Sung Kim
Cardiovascular Therapeutics.2018;36(3)e12324
[DOI]
  Feedback 
  Subscribe